Clinical Trials Logo
  1. Home
  2. Bacterial Keratitis
  3. NCT03845374

Prospective, Randomized Multi-Center Study of Using the Hyper-CL™ Lens in Subjects Suffering From Bacterial Keratitis

Bacterial Keratitis Clinical Trial

Official title:
Prospective, Randomized Multi-Center Study of Using the Hyper-CL™ Lens in Subjects Suffering From Bacterial Keratitis

Clinical Trial Summary

This study is a prospective, randomized, open-label, two arms, clinical study aim to evaluate the efficacy and safety of treatment with Hyper-CL™ lens + Antibiotics compared with treatment with Antibiotics only, in subjects with Bacterial keratitis. The design of the Hyper-CL™ lens increases contact time of the antibiotics on the cornea enabling increased bioavailability of the active drug.

Clinical Trial Description

The Hyper-CL™ Therapeutic soft contact lenses for short-term wear (up to 7 days) are indicated for therapeutic use to promote corneal healing and relieve corneal pain by protecting the cornea during the treatment of acute or chronic pathologies, such as corneal edema, corneal erosions, entropion, bullous keratopathy, and corneal dystrophies as well as post-surgical conditions resulting from cataract extraction and corneal surgery. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03845374
Study type Interventional
Source Eye-yon Medical
Contact
Status Completed
Phase N/A
Start date March 13, 2019
Completion date January 11, 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT02497365 - Besifloxacin in Bacterial Keratitis N/A
Terminated NCT02088970 - Safety and Efficacity of Corneal Collagen Crosslinking in Infectious Keratitis (Bacterial and Fungal ): Randomized,Controlled, Prospective Study. (CXL) N/A
Recruiting NCT03918408 - Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Collagen Cross-Linking in Eyes With Corneal Thinning Conditions Phase 1
Completed NCT00651586 - Safety and Efficacy Study of Gatifloxacin Compared With Ciprofloxacin in Patients With Acute Bacterial Corneal Ulcers Phase 2
Recruiting NCT06451172 - Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis Early Phase 1
Recruiting NCT02016989 - Matrix Therapy And Bacterial Keratitis N/A
Completed NCT00386958 - A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers Phase 2
Recruiting NCT04213885 - Safety and Effectiveness of the PXL Platinum 330 System for Corneal Collagen Cross-Linking in Eyes With Corneal Thinning Position Phase 2
Completed NCT01831206 - Collagen Cross-linking in Infectious Keratitis Trial Phase 2
Completed NCT00707005 - Antibiotic Susceptibility of Conjunctival Bacterial Isolates From Refractive Surgery Patients N/A
Completed NCT05655689 - The Antibiogram and Outcomes of Antimicrobial Regimens in Microbial Keratitis: A Prospective Cohort Study
Not yet recruiting NCT06271772 - Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction II Phase 3